Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Skin Cancer01:30

Skin Cancer

6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Mutations01:35

Mutations

45.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility.

Gels (Basel, Switzerland)·2026
Same author

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Blood advances·2026
Same author

Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis.

Blood·2026
Same author

In Reply to Oertel et al.

International journal of radiation oncology, biology, physics·2026
Same author

Optimization of Antioxidant Flavonoids Extraction From Helianthus annuus L. Ray Florets for Cardioprotective Nutraceuticals.

Chemistry & biodiversity·2025
Same author

Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups.

The Lancet. Haematology·2025

Related Experiment Video

Updated: Apr 1, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K

Radiation Therapy for Cutaneous T-Cell Lymphomas.

Daniel J Tandberg1, Oana Craciunescu1, Chris R Kelsey1

  • 1Department of Radiation Oncology, Duke University Medical Center, DUMC BOX 3085, Durham, NC 27710, USA.

Dermatologic Clinics
|October 5, 2015
PubMed
Summary

Radiation therapy offers an effective treatment for cutaneous T-cell lymphomas, including mycosis fungoides. It provides curative potential for early-stage disease and effective palliation for advanced stages, penetrating thick lesions.

Keywords:
CD30(+) lymphoproliferative disordersCutaneous T-cell lymphomaMycosis fungoidesRadiation therapyTotal skin electron beam therapy

More Related Videos

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.4K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Related Experiment Videos

Last Updated: Apr 1, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.4K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Area of Science:

  • Oncology
  • Dermatology

Background:

  • Cutaneous T-cell lymphomas (CTCL) are cancers affecting the skin.
  • Mycosis fungoides is the most common type of CTCL.
  • Skin-directed therapies are crucial for managing CTCL.

Purpose of the Study:

  • To highlight the efficacy of radiation therapy in managing CTCL.
  • To discuss the roles of radiation therapy in mycosis fungoides.
  • To compare radiation therapy with other skin-directed treatments.

Main Methods:

  • Review of radiation therapy's application in CTCL.
  • Analysis of treatment outcomes for mycosis fungoides.
  • Comparison of radiation therapy's penetration and effectiveness.

Main Results:

  • Lymphocytes in CTCL are highly sensitive to radiation.
  • Complete responses are achievable with low radiation doses.
  • Radiation therapy is effective for both early and advanced CTCL stages.
  • It offers curative potential for unilesional disease.
  • It provides palliation and local control for advanced disease.
  • Radiation therapy penetrates thick plaques and tumors effectively.

Conclusions:

  • Radiation therapy is a highly effective skin-directed treatment for CTCL.
  • It offers significant benefits over other skin-directed therapies due to its penetration.
  • It plays a vital role in the management of mycosis fungoides across disease stages.